Macrogenics Inc (MGNX)
4.71
+0.26
(+5.84%)
USD |
NASDAQ |
May 15, 16:00
4.71
0.00 (0.00%)
After-Hours: 16:31
Macrogenics Gross Profit (Quarterly): 6.988M for March 31, 2024
Gross Profit (Quarterly) Chart
Historical Gross Profit (Quarterly) Data
Date | Value |
---|---|
March 31, 2024 | 6.988M |
December 31, 2023 | 9.001M |
September 30, 2023 | 7.038M |
June 30, 2023 | 11.96M |
March 31, 2023 | 20.97M |
December 31, 2022 | 69.38M |
September 30, 2022 | 38.59M |
June 30, 2022 | 23.60M |
March 31, 2022 | 10.62M |
Date | Value |
---|---|
December 31, 2021 | 11.40M |
September 30, 2021 | 14.00M |
June 30, 2021 | 30.74M |
March 31, 2021 | 16.05M |
December 31, 2020 | 51.75M |
September 30, 2020 | 17.42M |
June 30, 2020 | 15.64M |
March 31, 2020 | 12.97M |
Gross Profit Definition
Gross profit is the difference between sales and the cost of goods sold. Revenues (aka Sales) less Cost of Goods Sold (COGS) is a company's gross profit. For many companies, cost of goods sold is a substantial portion of expenses.
Gross Profit (Quarterly) Range, Past 5 Years
6.988M
Minimum
Mar 2024
69.38M
Maximum
Dec 2022
21.65M
Average
15.64M
Median
Jun 2020
Gross Profit (Quarterly) Benchmarks
Moderna Inc | 71.00M |
Allurion Technologies Inc | 6.43M |
United Therapeutics Corp | 604.80M |
MEI Pharma Inc | -- |
Marinus Pharmaceuticals Inc | 6.923M |